Diligence memo · auto-generated · as of July 2, 2026
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Cloud Pharmaceuticals, Inc. operates in Pharmaceuticals, based in RTP.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cloud Pharmaceuticals, Inc. has raised $1.6M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $690K on 2011-06-02.
Most recent recorded round closed around 2015-07-01.
Valuation (modeled)modeled
Provath models Cloud Pharmaceuticals, Inc. at approximately $17M (range $196K–$188M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.46× the median modeled value of Pre-Seed Pharmaceuticals companies in 2013–2015 (87 peers) — value vs value, same stage and era. Within the normal band (146% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 11.0 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.6× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 24% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 25% of those peers.
Closest niche peers: IPM Safety Services, Inc., Scioderm, LLC, Chondrial Therapeutics, LLC, OnCore Biopharma, Inc., VR1 Corp.
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.